News

Probactive Biotech said that it has combined medical-grade Iodine-131 and Yttrium-90 with antitumor antibodies, producing targeted anticancer activity. The parts of the research and development program is expected

The new facility is expected to allow OvaGene Oncology to perform genomic testing on cancer cells using advanced technologies such as Quantitative Polymerase Chain Reaction (QPCR), Comparative Genomic

Lucentis is a vascular endothelial growth factor (VEGF) inhibitor which was first approved by the FDA for the treatment of neovascular (wet) age-related macular degeneration (AMD) in 2006.

Scil Proteins’ product, SPVF 2801, an Affilin molecule for applications in solid tumors passed initial preclinical studies with good results. Affilin molecules are scaffold proteins derived from the

GSK and Medivir claimed that Xerclear is the first and only topical herpes labialis (cold sores) treatment clinically proven to help prevent cold sore lesions appearing. As per

Beta-lactam antibiotics represent a class of drugs with a wide spectrum of antibacterial activity. Hospira said that Meropenem represents the first US drug launch from its recent acquisition

EdgeBio claimed that its Science Service concept includes everything starting from experiment and project design, to sample preparation, library construction, amplification and sequencing, bioinformatics, and reporting. CLC bio’s

The various aspects evaluated during the inspection include line production, laboratory safety, production control, inventory logistics on over 100 products, upkeep of the physical property, and proper management

Earlier, in December 2009, AstraZeneca and Targacept have signed a collaboration and license agreement for the development and commercialisation of TC-5214. TC-5214 Phase 3 program, referred to as